Literature DB >> 24592080

Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model.

Nilüfer Çetinkaya Kocadal1, Rukset Attar1, Gazi Yıldırım1, Cem Fıçıcıoğlu1, Ferda Ozkan2, Bayram Yılmaz3, Narter Yesildaglar1.   

Abstract

OBJECTIVE: We aimed to determine the effects of melatonin treatment on endometrial implants in an oopherectomized rat endometriosis model.
MATERIAL AND METHODS: This study is a prospective, randomised, controlled experimental study. It was carried out at the Experimental Research Center of Yeditepe University (YUDETAM). Twenty-two, female, non-pregnant, nulligravid Spraque-Dawley albino rats were included in our study. Endometriosis was surgically induced in oopherectomized rats. Rats were randomised into two groups: control group and melatonin group. In the melatonin group, rats were treated with melatonin (20 mg/kg/day) for two weeks. After the operations were performed to assess the regression of the endometriotic lesions, melatonin treatment was stopped. At the end of the sixth week necropsies were performed to assess the rate of recurrence. The volume and histopathological scores of endometriotic foci were examined.
RESULTS: Volumes of the endometriotic lesions significantly decreased in the melatonin group. Also, when the melatonin group was analysed within itself, endometriotic lesion volumes decreased and histopathological scores increased significantly.
CONCLUSION: Melatonin causes regression of the endometriotic lesions in rats and improvement in their histopathological scores.

Entities:  

Keywords:  Endometriosis; histopathological score; melatonin; oopherectomized rats; volume

Year:  2013        PMID: 24592080      PMCID: PMC3881748          DOI: 10.5152/jtgga.2013.53179

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  48 in total

Review 1.  Female infertility and free radicals: potential role in adhesions and endometriosis.

Authors:  Zeynep Alpay; Ghassan M Saed; Michael P Diamond
Journal:  J Soc Gynecol Investig       Date:  2006-07-26

2.  Total antioxidant status of peritoneal fluid in infertile women.

Authors:  G Polak; M Kozioł-Montewka; M Gogacz; I Błaszkowska; J Kotarski
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2001-02       Impact factor: 2.435

3.  Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis.

Authors:  T Collette; R Maheux; J Mailloux; A Akoum
Journal:  Hum Reprod       Date:  2006-07-31       Impact factor: 6.918

Review 4.  Role of oxidative stress in endometriosis.

Authors:  Sajal Gupta; Ashok Agarwal; Natalie Krajcir; Juan G Alvarez
Journal:  Reprod Biomed Online       Date:  2006-07       Impact factor: 3.828

Review 5.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

Review 6.  Activation mechanisms of matrix metalloproteinases.

Authors:  H Nagase
Journal:  Biol Chem       Date:  1997 Mar-Apr       Impact factor: 3.915

7.  Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis.

Authors:  Sumit Paul; Anamika Vivek Sharma; Pramathes Das Mahapatra; Partha Bhattacharya; Russel J Reiter; Snehasikta Swarnakar
Journal:  J Pineal Res       Date:  2008-02-19       Impact factor: 13.007

Review 8.  Immunology and endometriosis.

Authors:  Murat Berkkanoglu; Aydin Arici
Journal:  Am J Reprod Immunol       Date:  2003-07       Impact factor: 3.886

9.  Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2.

Authors:  Catherine Uzan; Annie Cortez; Charlotte Dufournet; Raffaèle Fauvet; Jean-Pierre Siffroi; Emile Daraï
Journal:  Virchows Arch       Date:  2004-09-28       Impact factor: 4.064

10.  Incidence of pelvic endometriosis in Rochester, Minnesota, 1970-1979.

Authors:  D E Houston; K L Noller; L J Melton; B J Selwyn; R J Hardy
Journal:  Am J Epidemiol       Date:  1987-06       Impact factor: 4.897

View more
  4 in total

1.  Melatonin activity and receptor expression in endometrial tissue and endometriosis.

Authors:  A A Mosher; M W Tsoulis; J Lim; C Tan; S K Agarwal; N A Leyland; W G Foster
Journal:  Hum Reprod       Date:  2019-07-08       Impact factor: 6.918

2.  Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in advanced stage endometriosis with endometrioma.

Authors:  Ali Yavuzcan; Mete Cağlar; Yusuf Ustün; Serdar Dilbaz; Ismail Ozdemir; Elif Yıldız; Atilla Ozkara; Selahattin Kumru
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-12-01

Review 3.  Melatonin in Endometriosis: Mechanistic Understanding and Clinical Insight.

Authors:  Yiran Li; Sze-Wan Hung; Ruizhe Zhang; Gene Chi-Wai Man; Tao Zhang; Jacqueline Pui-Wah Chung; Lanlan Fang; Chi-Chiu Wang
Journal:  Nutrients       Date:  2022-10-01       Impact factor: 6.706

4.  Melatonin inhibits 17β-estradiol-induced migration, invasion and epithelial-mesenchymal transition in normal and endometriotic endometrial epithelial cells.

Authors:  Shasha Qi; Lei Yan; Zhao Liu; Yu-Lan Mu; Mingjiang Li; Xingbo Zhao; Zi-Jiang Chen; Hui Zhang
Journal:  Reprod Biol Endocrinol       Date:  2018-06-23       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.